Researchers studied 368 people in New York with an average age of 44 who had been diagnosed with MS for an average of 12 years. Participants underwent brain scans and were asked about their smoking history.
Of the group, 240 were non-smokers, 96 were current smokers and 32 were past smokers. Current smokers were considered people who smoked more than 10 cigarettes per day in the three months leading up to the study and past smokers were those who smoked for at least six months sometime before the start of the study. The average current smoker in the study had been smoking for 18 years.
The study found that smokers with MS had a greater breakdown of the barrier between the brain and blood and had nearly 17 percent more brain lesions on their scans compared to non-smokers with MS. Smokers with MS had 13 percent larger ventricles and a smaller brain size compared to non-smokers with MS.
“These results show that smoking appears to quite literally injure the brain in a person with multiple sclerosis and increases the risk of disease severity and progression,” said study author Robert Zivadinov, MD, PhD, Associate Professor with State University of New York School of Medicine and Biomedical Sciences in Buffalo. Zivadinov is also the Director of the Buffalo Neuroimaging Analysis Center, the Jacobs Neurological Institute and a member of the American Academy of Neurology. “Our study stresses the importance of anti-smoking education in schools, where many smokers start, and more targeted programs to help people with MS to quit smoking so they can have a better quality of life.”
The study also found that smokers were likely to have more problems with motor functioning, such as walking and taking part in daily activities, than non-smokers.
The study was supported by the National Multiple Sclerosis Society.
The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Parkinson’s disease, ALS (Lou Gehrig’s disease), dementia, West Nile virus, and ataxia.
For more information about the American Academy of Neurology, visit http://www.aan.com or www.thebrainmatters.org.View the August 18, 2009, NEUROLOGY® Print Publication’s Table of Contents
Rachel L. Seroka | American Academy of Neurology
Study relating to materials testing Detecting damages in non-magnetic steel through magnetism
23.07.2018 | Technische Universität Kaiserslautern
Innovative genetic tests for children with developmental disorders and epilepsy
11.07.2018 | Christian-Albrechts-Universität zu Kiel
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences